Kevin D. Judy
Expertise in
28
conditions

Dr. Kevin D. Judy

Neurosurgery
950 Pulaski Drive, Suite 120, 
King Of Prussia, PA 
Accepting New Patients
Offers Telehealth
Expertise in
28
conditions
950 Pulaski Drive, Suite 120, 
King Of Prussia, PA 

Overview

Kevin Judy is a Neurosurgery provider in King Of Prussia, Pennsylvania. Dr. Judy is highly rated in 28 conditions, according to our data. His top areas of expertise are Glioma, Meningioma, Astrocytoma, Awake Craniotomy, and Gamma Knife Radiosurgery. Dr. Judy is currently accepting new patients.

His clinical research consists of co-authoring 42 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

University Of Pittsburgh School Of Medicine

Residency

Johns Hopkins Hospital

Specialties

Neurosurgery

Licenses

Neurological Surgery in PA

Board Certifications

Neurological Surgery

Fellowships

Johns Hopkins Hospital

Hospital Affiliations

Thomas Jefferson University Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Vickie & Jack Farber Institute for Neuroscience - 950 Pulaski Drive
950 Pulaski Drive, Suite 120, King Of Prussia, PA 19406
Other Locations
Jefferson Neurological Surgery Associates
1101 Chestnut Street, Floor 10, Philadelphia, PA 19107

Additional Areas of Focus

Dr. Judy has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Astrocytoma
Brain Tumor
Chiari Malformation
Acoustic Neuroma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Analysis of Cell Count, Viability, and Immunogenicity of Deidentified Discarded Newly Diagnosed Glioblastoma Tissue and More Broadly Other Newly Diagnosed Solid Tumor Tissues From the Operating Room
Analysis of Cell Count, Viability, and Immunogenicity of Deidentified Discarded Newly Diagnosed Glioblastoma Tissue and More Broadly Other Newly Diagnosed Solid Tumor Tissues From the Operating Room
Enrollment Status: Completed
Publish Date: February 10, 2026
Intervention Type: Procedure
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Safety and Efficacy of IGV-001, an Autologous Cell Immunotherapy With Antisense Oligonucleotide (IMV-001) Targeting IGF-1R, in Newly Diagnosed Patients With Glioblastoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Safety and Efficacy of IGV-001, an Autologous Cell Immunotherapy With Antisense Oligonucleotide (IMV-001) Targeting IGF-1R, in Newly Diagnosed Patients With Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: February 10, 2026
Intervention Type: Combination product, Procedure, Drug
Study Drugs: IGV-001 Cell Immunotherapy, Temozolomide
Study Phase: Phase 2
Phase I Study in Humans Evaluating the Safety of Rectus Sheath Implantation of Diffusion Chambers Encapsulating Autologous Malignant Glioma Cells Treated With Insulin-like Growth Factor Receptor-1 Antisense Oligodeoxynucleotide (IGF-1R/AS ODN) in 32 Patients With Newly Diagnosed Malignant Glioma
Phase I Study in Humans Evaluating the Safety of Rectus Sheath Implantation of Diffusion Chambers Encapsulating Autologous Malignant Glioma Cells Treated With Insulin-like Growth Factor Receptor-1 Antisense Oligodeoxynucleotide (IGF-1R/AS ODN) in 32 Patients With Newly Diagnosed Malignant Glioma
Enrollment Status: Completed
Publish Date: May 07, 2025
Intervention Type: Drug
Study Phase: Phase 1
Phase I Study of Alisertib With Concurrent Fractionated Stereotactic Radiation Treatment for Recurrent High Grade Gliomas
Phase I Study of Alisertib With Concurrent Fractionated Stereotactic Radiation Treatment for Recurrent High Grade Gliomas
Enrollment Status: Completed
Publish Date: April 30, 2025
Intervention Type: Drug, Radiation, Procedure
Study Phase: Phase 1
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry
Enrollment Status: Completed
Publish Date: April 24, 2025
Intervention Type: Device
View 4 Less Clinical Trials

42 Total Publications

Recurrent intracranial myoepithelioma: clinical course and long-term follow-up. Illustrative case.
Recurrent intracranial myoepithelioma: clinical course and long-term follow-up. Illustrative case.
Journal: Journal of neurosurgery. Case lessons
Published: February 26, 2025
Similar Doctors
Expertise in
28
conditions
Dr. Donald M. O'rourke
Neurosurgery
Expertise in
28
conditions
Dr. Donald M. O'rourke
Neurosurgery

Penn Gamma Knife Center

801 Spruce Street, Spruce Building, 1st Floor, 
Philadelphia, PA 
 (0.3 miles away)
215-662-3487
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Donald O'rourke is a Neurosurgery provider in Philadelphia, Pennsylvania. Dr. O'rourke is highly rated in 28 conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Gastrostomy. Dr. O'rourke is currently accepting new patients.

Expertise in
20
conditions
Dr. Steven Brem
Neurosurgery
Expertise in
20
conditions
Dr. Steven Brem
Neurosurgery

Trustees Of The University Of Pennsylvania

3400 Spruce St, 
Philadelphia, PA 
 (2.0 miles away)
215-662-3487
Languages Spoken:
English
See accepted insurances

Steven Brem is a Neurosurgery provider in Philadelphia, Pennsylvania. Dr. Brem is highly rated in 20 conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Gastrostomy.

Expertise in
23
conditions
Dr. Jan-karl Burkhardt
Neurosurgery
Expertise in
23
conditions
Dr. Jan-karl Burkhardt
Neurosurgery

Penn Neuroscience Center Radnor - Neurosurgery

145 King Of Prussia Road, Floor 3, Suite 304, 
Radnor, PA 
 (12.3 miles away)
215-662-3487
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jan-karl Burkhardt is a Neurosurgery provider in Radnor, Pennsylvania. Dr. Burkhardt is highly rated in 23 conditions, according to our data. His top areas of expertise are Brain Aneurysm, Chronic Subdural Hematoma, Subdural Hematoma, Extracranial-Intracranial Bypass Surgery, and Cerebral Artery Bypass Surgery. Dr. Burkhardt is currently accepting new patients.

Frequently Asked Questions about Dr. Kevin D. Judy

How do I make an appointment with Dr. Kevin D. Judy?

You can book an appointment with Dr. Kevin D. Judy by calling their office at 215-955-7000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kevin D. Judy a top-rated expert for Glioma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kevin D. Judy is classified as an Elite expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kevin D. Judy specialize in?

While Dr. Kevin D. Judy is a Neurosurgery, they have specific expertise in Glioma, Meningioma, and Astrocytoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurosurgery.

Does Dr. Kevin D. Judy participate in research or clinical trials?

Yes. Dr. Kevin D. Judy has published 42 articles and abstracts on conditions like Glioma. You can view a list of Dr. Kevin D. Judy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kevin D. Judy accept my insurance?

Dr. Kevin D. Judy accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 215-955-7000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Judy's expertise for a condition
ConditionClose
View All 15 Distinguished Conditions
View All 8 Advanced Conditions
View All 45 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile